B2DG Events - This Year

Topic Speaker Title Company Datesort icon Location
If you build it, who will pay for it? Pam Baker Senior Director of Market Access & Policy, Sales Strategy, Training and Operations CardioDx 10/14/2014 - 6:00pm Wilson
Rocket Science Meets Biotech At The Frontier of Digital Health Chris Melton CEO & Founder Corvectra 09/30/2014 - 8:30am Sunnyvale
Leveraging Wearable Technology to Monitor Chronic Health Conditions Anoo Nathan CEO Smart Monitor 09/23/2014 - 8:30am Sunnyvale
Opportunities and Challenges for MedTech Companies in Evolving Reform and Reimbursement Landscape Jessica Holmes Director of Reimbursement Argenta Advisors 09/16/2014 - 8:30am Sunnyvale
Reimbursement Challenges for Class II Medical Devices Daniel Cher, MD Vice President of Clinical Affairs SI-Bone 09/09/2014 - 6:00pm Wilson
Bio-Mimicry Concepts for Targeted Drug Delivery Jayakurma Rajadas Director, BIOADD AND Assistant Director OF CV Pharmacology, BIOADD Service Center Stanford 09/02/2014 - 8:30am Sunnyvale
Drug Development in silico: Models and Their Utility Toufigh Gordi President ROSA and Company Drug Development Advisors 08/26/2014 - 8:30am Sunnyvale
What ASQ can mean for you in Silicon Valley Marieann Shovlin Education Chair at Silicon Valley ASQ, Founder and Principal at Peak Process Co. 08/19/2014 - 8:30am Sunnyvale
Joint B2DG and EPPIC Event--Diabetes and Cardiovascular Disease Risk Factors in Multi-Ethnic Groups Comparison Study Findings from the MASALA study Alka M. Kanaya, M.D. Professor of Medicine, General Internal Medicine University of California, San Francisco 08/12/2014 - 6:00pm Wilson
Open Forum Discussions Harry Wachob and members of B2DG B2DG 08/05/2014 - 8:30am Sunnyvale
Microneedles: Breaking the (Skin) Barrier for Drug Delivery and Diagnostics Janet Tamada, PhD Principal & Founder J Tamada Consulting 07/29/2014 - 8:30am Sunnyvale
Tele-medicine and Mobile HealthTech Hrishikesh Amravatkar CEO Co-Founder DoctorQuickly 07/22/2014 - 8:30am Sunnyvale
Challenges in Developing Drugs for Orphan Indications: The Story of Neuraltus and ALS Richard L. Casey President and CEO Neuraltus Pharmaceuticals 07/15/2014 - 8:30am Sunnyvale
Ca2+ Sensitizers - Opportunities in Drug Development Ullrich Steven Schwertschlag, M.D, PHD, FACP, FCP Pharmaceutical Drug Developer . 07/08/2014 - 6:00pm Wilson
Trak FertilityTM - A Military-Grade Sperm Counter? Greg Sommer CEO Sandstone Diagnostics 07/01/2014 - 8:30am Sunnyvale
Health Information Technology (HIT): The Promise of a Better Healthcare System? Salim Kizaraly SVP Business Development and Founder Stella Technology 06/24/2014 - 8:30am Sunnyvale
Using a Case Study Approach to Describing the Key Drivers of Reimbursement Strategy Planning Susan Rowinski President Rowinski Group LLC 06/17/2014 - 8:30am Sunnyvale
Critical Issues in International Women's Health Anne Firth Murray Consulting professor of International Women's Health Stanford University 06/10/2014 - 6:00pm Wilson
iCGM - A Continuous Glucose Monitoring System Lu Wang Founder and CEO Sageland Technologies and Suzhou Metis Biomed 06/03/2014 - 8:30am Sunnyvale
Breastfeeding support using Google Glass Madeline Sands Leader of the Breastfeeding Support Project Small World Social 05/27/2014 - 8:30am Sunnyvale
Creating a Winning Life Science Product Marketing Plan Audrey S. Erbes, Ph.D. Principal Erbes & Associates and Audreysnetwork.com 05/20/2014 - 8:30am Sunnyvale
The Global Tilt and Why You Must Rethink the Future of Medical Technology Thomas M. Loarie Chairman Mercator MedSystem; 05/13/2014 - 6:00pm Wilson
Preventing Drug-Related Patient Injury and Death With Advanced, Cost-Effective Technology Systems Alan Jacobs, MD, PhD Founder & CEO PerceptiMed 05/06/2014 - 8:30am Sunnyvale
Developing Oncolytic Virus to Treat Glioblastoma Michelle Chen, Ph.D. Chief Business Officer DNAtrix 04/29/2014 - 8:30am Sunnyvale
Medical Device and Diagnostics Industry Trends Terri Sampo Founder and Principal Consultant Clinical Trial Data Services 04/22/2014 - 8:30am Sunnyvale
Path to developing cost effective solutions for therapeutic monoclonal antibodies Amita Goel Founder and CEO Celltheon Corporation 04/15/2014 - 8:30am Sunnyvale

B2DG Events Search